{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:24:57Z","timestamp":1787599497787,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100023181","name":"Agencja Bada\u0144 Medycznych","doi-asserted-by":"publisher","award":["KPOD.07.07-IW.07-0099\/24"],"award-info":[{"award-number":["KPOD.07.07-IW.07-0099\/24"]}],"id":[{"id":"10.13039\/501100023181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023181","name":"Agencja Bada\u0144 Medycznych","doi-asserted-by":"publisher","award":["KPOD.07.07-IW.07-0099\/24"],"award-info":[{"award-number":["KPOD.07.07-IW.07-0099\/24"]}],"id":[{"id":"10.13039\/501100023181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023181","name":"Agencja Bada\u0144 Medycznych","doi-asserted-by":"publisher","award":["KPOD.07.07-IW.07-0099\/24"],"award-info":[{"award-number":["KPOD.07.07-IW.07-0099\/24"]}],"id":[{"id":"10.13039\/501100023181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023181","name":"Agencja Bada\u0144 Medycznych","doi-asserted-by":"publisher","award":["KPOD.07.07-IW.07-0099\/24"],"award-info":[{"award-number":["KPOD.07.07-IW.07-0099\/24"]}],"id":[{"id":"10.13039\/501100023181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023181","name":"Agencja Bada\u0144 Medycznych","doi-asserted-by":"publisher","award":["KPOD.07.07-IW.07-0099\/24"],"award-info":[{"award-number":["KPOD.07.07-IW.07-0099\/24"]}],"id":[{"id":"10.13039\/501100023181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023181","name":"Agencja Bada\u0144 Medycznych","doi-asserted-by":"publisher","award":["KPOD.07.07-IW.07-0099\/24"],"award-info":[{"award-number":["KPOD.07.07-IW.07-0099\/24"]}],"id":[{"id":"10.13039\/501100023181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023181","name":"Agencja Bada\u0144 Medycznych","doi-asserted-by":"publisher","award":["KPOD.07.07-IW.07-0099\/24"],"award-info":[{"award-number":["KPOD.07.07-IW.07-0099\/24"]}],"id":[{"id":"10.13039\/501100023181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023181","name":"Agencja Bada\u0144 Medycznych","doi-asserted-by":"publisher","award":["KPOD.07.07-IW.07-0099\/24"],"award-info":[{"award-number":["KPOD.07.07-IW.07-0099\/24"]}],"id":[{"id":"10.13039\/501100023181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023181","name":"Agencja Bada\u0144 Medycznych","doi-asserted-by":"publisher","award":["KPOD.07.07-IW.07-0099\/24"],"award-info":[{"award-number":["KPOD.07.07-IW.07-0099\/24"]}],"id":[{"id":"10.13039\/501100023181","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"DOI":"10.1007\/s43440-026-00889-9","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:28:31Z","timestamp":1787552911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["preSCRIPT: Large-scale prescription search and annotation engine for pharmacogenomic studies"],"prefix":"10.1007","author":[{"given":"Maria","family":"Pieczarka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Pie\u0144kowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Konowalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Grubarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7103-4246","authenticated-orcid":false,"given":"Jacek","family":"Hajto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u017cesika","family":"Hoinkis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2468-151X","authenticated-orcid":false,"given":"Marcin","family":"Piechota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4304-8384","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Borczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4273-7401","authenticated-orcid":false,"given":"Micha\u0142","family":"Korosty\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"889_CR1","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00439-022-02456-7","volume":"141","author":"GP Patrinos","year":"2022","unstructured":"Patrinos GP, Shuldiner AR. Pharmacogenomics: the low-hanging fruit in the personalized medicine tree. Hum Genet. 2022;141:1109\u201311. https:\/\/doi.org\/10.1007\/s00439-022-02456-7.","journal-title":"Hum Genet"},{"key":"889_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0140-6736(22)01841-4","volume":"401","author":"JJ Swen","year":"2023","unstructured":"Swen JJ, van der Wouden CH, Manson LE, Abdullah-Koolmees H, Blagec K, Blagus T, et al. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. Lancet. 2023;401:347\u201356. https:\/\/doi.org\/10.1016\/S0140-6736(22)01841-4.","journal-title":"Lancet"},{"key":"889_CR3","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/clpt.2010.279","volume":"89","author":"MV Relling","year":"2011","unstructured":"Relling MV, Klein TE. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clin Pharmacol Ther. 2011;89:464\u20137. https:\/\/doi.org\/10.1038\/clpt.2010.279.","journal-title":"Clin Pharmacol Ther"},{"key":"889_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/cpt.2350","volume":"110","author":"M Whirl-Carrillo","year":"2021","unstructured":"Whirl-Carrillo M, Huddart R, Gong L, Sangkuhl K, Thorn CF, Whaley R, et al. An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine. Clin Pharmacol Ther. 2021;110:563\u201372. https:\/\/doi.org\/10.1002\/cpt.2350.","journal-title":"Clin Pharmacol Ther"},{"key":"889_CR5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41576-022-00572-8","volume":"24","author":"M Pirmohamed","year":"2023","unstructured":"Pirmohamed M. Pharmacogenomics: current status and future perspectives. Nat Rev Genet. 2023;24:350\u201362. https:\/\/doi.org\/10.1038\/s41576-022-00572-8.","journal-title":"Nat Rev Genet"},{"key":"889_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203\u20139. https:\/\/doi.org\/10.1038\/s41586-018-0579-z.","journal-title":"Nature"},{"key":"889_CR7","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12:e1001779. https:\/\/doi.org\/10.1371\/journal.pmed.1001779.","journal-title":"PLoS Med"},{"key":"889_CR8","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/ije\/dyt268","volume":"44","author":"L Leitsalu","year":"2015","unstructured":"Leitsalu L, Haller T, Esko T, Tammesoo M-L, Alavere H, Snieder H, et al. Cohort Profile: Estonian Biobank of the Estonian Genome Center, University of Tartu. Int J Epidemiol. 2015;44:1137\u201347. https:\/\/doi.org\/10.1093\/ije\/dyt268.","journal-title":"Int J Epidemiol"},{"key":"889_CR9","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613:508\u201318. https:\/\/doi.org\/10.1038\/s41586-022-05473-8.","journal-title":"Nature"},{"key":"889_CR10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1056\/NEJMsr1809937","volume":"381","author":"JC Denny","year":"2019","unstructured":"All of Us Research Program Investigators, Denny JC, Rutter JL, Goldstein DB, Philippakis A, Smoller JW, et al. The All of Us Research Program. N Engl J Med. 2019;381:668\u201376. https:\/\/doi.org\/10.1056\/NEJMsr1809937.","journal-title":"N Engl J Med"},{"key":"889_CR11","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/cpt.2122","volume":"109","author":"G McInnes","year":"2021","unstructured":"McInnes G, Lavertu A, Sangkuhl K, Klein TE, Whirl-Carrillo M, Altman RB. Pharmacogenetics at Scale: An Analysis of the UK Biobank. Clin Pharmacol Ther. 2021;109:1528\u201337. https:\/\/doi.org\/10.1002\/cpt.2122.","journal-title":"Clin Pharmacol Ther"},{"key":"889_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41397-026-00399-0","volume":"26","author":"J Hajto","year":"2026","unstructured":"Hajto J, Piechota M, Kr\u00e4tschmer I, Konowalska P, Boyle GE, Fowler DM, et al. Computational variant predictors for pharmacogenomics: from evaluation of single alleles to assessment of adverse drug reactions to antidepressants. Pharmacogenomics J. 2026;26:8. https:\/\/doi.org\/10.1038\/s41397-026-00399-0.","journal-title":"Pharmacogenomics J"},{"key":"889_CR13","doi-asserted-by":"publisher","first-page":"e13871","DOI":"10.1111\/cts.13871","volume":"17","author":"E Jafari","year":"2024","unstructured":"Jafari E, Blackman MH, Karnes JH, Van Driest SL, Crawford DC, Choi L, et al. Using electronic health records for clinical pharmacology research: Challenges and considerations. Clin Transl Sci. 2024;17:e13871. https:\/\/doi.org\/10.1111\/cts.13871.","journal-title":"Clin Transl Sci"},{"key":"889_CR14","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/jamia\/ocab260","volume":"29","author":"P Darke","year":"2022","unstructured":"Darke P, Cassidy S, Catt M, Taylor R, Missier P, Bacardit J. Curating a longitudinal research resource using linked primary care EHR data\u2014a UK Biobank case study. J Am Med Inf Assoc. 2022;29:546\u201352. https:\/\/doi.org\/10.1093\/jamia\/ocab260.","journal-title":"J Am Med Inf Assoc"},{"key":"889_CR15","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2025","unstructured":"Joint Formulary Committee. British National Formulary. London, England: BMJ Group and Pharmaceutical; 2025."},{"key":"889_CR16","doi-asserted-by":"publisher","unstructured":"Lo CWH, Handley D, Pain O, Kamp M, Gillett AC, Iveson MH et al. T-Rx: a toolbox for reproducible processing of prescriptions (Rx) from electronic health records 2025 [preprint]. https:\/\/doi.org\/10.1101\/2025.10.07.25336002.","DOI":"10.1101\/2025.10.07.25336002"},{"key":"889_CR17","first-page":"184","volume":"26","author":"G McInnes","year":"2021","unstructured":"McInnes G, Altman RB. Drug Response Pharmacogenetics for 200,000 UK Biobank Participants. Pac Symp Biocomput Pac Symp Biocomput. 2021;26:184\u201395.","journal-title":"Pac Symp Biocomput Pac Symp Biocomput"},{"key":"889_CR18","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1038\/s41467-025-58152-3","volume":"16","author":"MC Sadler","year":"2025","unstructured":"Sadler MC, Apostolov A, Cevallos C, Auwerx C, Ribeiro DM, Altman RB, et al. Leveraging large-scale biobank EHRs to enhance pharmacogenetics of cardiometabolic disease medications. Nat Commun. 2025;16:2913. https:\/\/doi.org\/10.1038\/s41467-025-58152-3.","journal-title":"Nat Commun"},{"key":"889_CR19","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1038\/s41380-021-01062-9","volume":"26","author":"C Fabbri","year":"2021","unstructured":"Fabbri C, Hagenaars SP, John C, Williams AT, Shrine N, Moles L, et al. Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts. Mol Psychiatry. 2021;26:3363\u201373. https:\/\/doi.org\/10.1038\/s41380-021-01062-9.","journal-title":"Mol Psychiatry"},{"key":"889_CR20","doi-asserted-by":"publisher","unstructured":"Li D, Lo CWH, Lewis CM, Vassos E, Breen G. Understanding antidepressant change patterns in the UK Biobank 2025[preprint]. https:\/\/doi.org\/10.1101\/2025.10.13.25337814.","DOI":"10.1101\/2025.10.13.25337814"},{"key":"889_CR21","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1365-2125.2007.03052.x","volume":"65","author":"MJ Bijl","year":"2008","unstructured":"Bijl MJ, Visser LE, Hofman A, Vulto AG, van Gelder T, Stricker BHC, et al. Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants. Br J Clin Pharmacol. 2008;65:558\u201364. https:\/\/doi.org\/10.1111\/j.1365-2125.2007.03052.x.","journal-title":"Br J Clin Pharmacol"},{"key":"889_CR22","doi-asserted-by":"publisher","unstructured":"Lavertu A, McInnes G, Tanigawa Y, Altman RB, Rivas MA. LPA and APOE are associated with statin selection in the UK Biobank 2020[preprint]. https:\/\/doi.org\/10.1101\/2020.08.28.272765.","DOI":"10.1101\/2020.08.28.272765"},{"key":"889_CR23","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/cpt.2527","volume":"111","author":"D Voora","year":"2022","unstructured":"Voora D, Baye J, McDermaid A, Narayana Gowda S, Wilke RA, Nicole Myrmoe A, et al. SLCO1B1*5 Allele Is Associated With Atorvastatin Discontinuation and Adverse Muscle Symptoms in the Context of Routine Care. Clin Pharmacol Ther. 2022;111:1075\u201383. https:\/\/doi.org\/10.1002\/cpt.2527.","journal-title":"Clin Pharmacol Ther"},{"key":"889_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jacl.2012.03.003","volume":"6","author":"JD Cohen","year":"2012","unstructured":"Cohen JD, Brinton EA, Ito MK, Jacobson TA. Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users. J Clin Lipidol. 2012;6:208\u201315. https:\/\/doi.org\/10.1016\/j.jacl.2012.03.003.","journal-title":"J Clin Lipidol"},{"key":"889_CR25","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","volume":"36","author":"ES Stroes","year":"2015","unstructured":"Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, et al. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J. 2015;36:1012\u201322. https:\/\/doi.org\/10.1093\/eurheartj\/ehv043.","journal-title":"Eur Heart J"},{"key":"889_CR26","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3390\/ph16091277","volume":"16","author":"WLE Wong","year":"2023","unstructured":"Wong WLE, Fabbri C, Laplace B, Li D, van Westrhenen R, Lewis CM, et al. The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank. Pharmaceuticals. 2023;16:1277. https:\/\/doi.org\/10.3390\/ph16091277.","journal-title":"Pharmaceuticals"},{"key":"889_CR27","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41431-025-01894-x","volume":"33","author":"HM Kariis","year":"2025","unstructured":"Kariis HM, S\u00e4rg D, Krebs K, J\u00f5eloo M, K\u00f5iv K, Sirts K, et al. Genetic influences on antidepressant side effects: a CYP2C19 gene variation and polygenic risk study in the Estonian Biobank. Eur J Hum Genet. 2025;33:1376\u201385. https:\/\/doi.org\/10.1038\/s41431-025-01894-x.","journal-title":"Eur J Hum Genet"},{"key":"889_CR28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1186\/s12967-025-06782-y","volume":"23","author":"S Kasela","year":"2025","unstructured":"Kasela S, Luitva LB, Krebs K, M\u00f6ls M, Milani L, Alver M, et al. Polygenic and pharmacogenomic contributions to medication dosing: a real-world longitudinal biobank study. J Transl Med. 2025;23:727. https:\/\/doi.org\/10.1186\/s12967-025-06782-y.","journal-title":"J Transl Med"},{"key":"889_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41591-022-02122-5","volume":"29","author":"T Kiiskinen","year":"2023","unstructured":"Kiiskinen T, Helkkula P, Krebs K, Karjalainen J, Saarentaus E, Mars N, et al. Genetic predictors of lifelong medication-use patterns in cardiometabolic diseases. Nat Med. 2023;29:209\u201318. https:\/\/doi.org\/10.1038\/s41591-022-02122-5.","journal-title":"Nat Med"},{"key":"889_CR30","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41586-022-04965-x","volume":"607","author":"BV Halldorsson","year":"2022","unstructured":"Halldorsson BV, Eggertsson HP, Moore KHS, Hauswedell H, Eiriksson O, Ulfarsson MO, et al. The sequences of 150,119 genomes in the UK Biobank. Nature. 2022;607:732\u201340. https:\/\/doi.org\/10.1038\/s41586-022-04965-x.","journal-title":"Nature"},{"key":"889_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/cpt.910","volume":"103","author":"A Gaedigk","year":"2018","unstructured":"Gaedigk A, Ingelman-Sundberg M, Miller NA, Leeder JS, Whirl-Carrillo M, Klein TE, et al. The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database. Clin Pharmacol Ther. 2018;103:399\u2013401. https:\/\/doi.org\/10.1002\/cpt.910.","journal-title":"Clin Pharmacol Ther"},{"key":"889_CR32","doi-asserted-by":"publisher","first-page":"D1152","DOI":"10.1093\/nar\/gkaf1218","volume":"54","author":"DJ Barker","year":"2026","unstructured":"Barker DJ, Natarajan RHL, Cooper MA, Hopper SJF, Yates AD, Parham P, et al. The IPD-IMGT\/HLA database: recent developments in sequence submission. Nucleic Acids Res. 2026;54:D1152\u20138. https:\/\/doi.org\/10.1093\/nar\/gkaf1218.","journal-title":"Nucleic Acids Res"},{"key":"889_CR33","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434\u201343. https:\/\/doi.org\/10.1038\/s41586-020-2308-7.","journal-title":"Nature"},{"key":"889_CR34","doi-asserted-by":"publisher","unstructured":"Gao F, Chang D, Biddanda A, Li M, Guo Y, Zhou Z, et al. XWAS: a software toolset for genetic data analysis and association studies of the X chromosome. J Hered. 2015;106:666\u201371. https:\/\/doi.org\/10.1093\/jhered\/esv059.","DOI":"10.1093\/jhered\/esv059"},{"key":"889_CR35","doi-asserted-by":"publisher","unstructured":"K\u00f6nig IR, Loley C, Erdmann J, Ziegler A. How to include chromosome X in your genome-wide association study. Genet Epidemiol. 2014;38:97\u2013103. https:\/\/doi.org\/10.1002\/gepi.21782.","DOI":"10.1002\/gepi.21782"},{"key":"889_CR36","unstructured":"England. accessed April 15, n.d;2026. https:\/\/nhsbsa-opendata.s3.eu-west-2.amazonaws.com\/pca\/pca_summary_narrative_2023_24_v001.html."},{"key":"889_CR37","doi-asserted-by":"publisher","unstructured":"Kasela S, Luitva LB, Krebs K, Team EBR, M\u00f6ls M, Milani L et al. Investigating the genetic factors of medication dosing using biobank-linked drug purchase data 2025[preprint]. https:\/\/doi.org\/10.1101\/2025.04.01.25325019.","DOI":"10.1101\/2025.04.01.25325019"},{"key":"889_CR38","doi-asserted-by":"publisher","unstructured":"Borczyk M, Machnik N, Hajto J, Kr\u00e4tschmer I, Konowalska P, Baszkiewicz B et al. Separating the genetics of disease, treatment, and treatment response using graphical modeling and large-scale electronic health records 2026[preprint]. https:\/\/doi.org\/10.1101\/2025.04.29.25326633.","DOI":"10.1101\/2025.04.29.25326633"},{"key":"889_CR39","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1093\/bioinformatics\/btaa520","volume":"36","author":"F Priv\u00e9","year":"2020","unstructured":"Priv\u00e9 F, Luu K, Blum MGB, McGrath JJ, Vilhj\u00e1lmsson BJ. Efficient toolkit implementing best practices for principal component analysis of population genetic data. Bioinformatics. 2020;36:4449\u201357. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa520.","journal-title":"Bioinformatics"},{"key":"889_CR40","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41588-022-01158-0","volume":"54","author":"A Abdellaoui","year":"2022","unstructured":"Abdellaoui A, Dolan CV, Verweij KJH, Nivard MG. Gene-environment correlations across geographic regions affect genome-wide association studies. Nat Genet. 2022;54:1345\u201354. https:\/\/doi.org\/10.1038\/s41588-022-01158-0.","journal-title":"Nat Genet"},{"key":"889_CR41","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17:122. https:\/\/doi.org\/10.1186\/s13059-016-0974-4.","journal-title":"Genome Biol"},{"key":"889_CR42","doi-asserted-by":"publisher","first-page":"bar030","DOI":"10.1093\/database\/bar030","volume":"2011","author":"RJ Kinsella","year":"2011","unstructured":"Kinsella RJ, K\u00e4h\u00e4ri A, Haider S, Zamora J, Proctor G, Spudich G, et al. Ensembl BioMarts: a hub for data retrieval across taxonomic space. Database. 2011;2011:bar030. https:\/\/doi.org\/10.1093\/database\/bar030.","journal-title":"Database"},{"key":"889_CR43","unstructured":"Polygenic. Accessed April 15, and pharmacogenomic contributions to medication dosing: a real-world longitudinal biobank study | J Transl Med. 2026. https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06782-y."},{"key":"889_CR44","doi-asserted-by":"publisher","first-page":"e525","DOI":"10.3399\/bjgp20X710873","volume":"70","author":"HJ Curtis","year":"2020","unstructured":"Curtis HJ, Walker AJ, MacKenna B, Croker R, Goldacre B. Prescription of suboptimal statin treatment regimens: a retrospective cohort study of trends and variation in English primary care. Br J Gen Pract. 2020;70:e525\u201333. https:\/\/doi.org\/10.3399\/bjgp20X710873.","journal-title":"Br J Gen Pract"},{"key":"889_CR45","doi-asserted-by":"publisher","first-page":"d4094","DOI":"10.1136\/bmj.d4094","volume":"343","author":"LAG Rodr\u00edguez","year":"2011","unstructured":"Rodr\u00edguez LAG, Cea-Soriano L, Mart\u00edn-Merino E, Johansson S. Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care. BMJ. 2011;343:d4094. https:\/\/doi.org\/10.1136\/bmj.d4094.","journal-title":"BMJ"},{"key":"889_CR46","doi-asserted-by":"publisher","first-page":"e070753","DOI":"10.1136\/bmj-2022-070753","volume":"383","author":"TM Caparrotta","year":"2023","unstructured":"Caparrotta TM, Carduff E, Dear JW. Paracetamol use in adults. BMJ. 2023;383:e070753. https:\/\/doi.org\/10.1136\/bmj-2022-070753.","journal-title":"BMJ"},{"key":"889_CR47","doi-asserted-by":"publisher","first-page":"e025331","DOI":"10.1136\/bmjopen-2018-025331","volume":"9","author":"E Kinnaird","year":"2019","unstructured":"Kinnaird E, Kimerg\u00e5rd A, Jennings S, Drummond C, Deluca P. From pain treatment to opioid dependence: a qualitative study of the environmental influence on codeine use in UK adults. BMJ Open. 2019;9:e025331. https:\/\/doi.org\/10.1136\/bmjopen-2018-025331.","journal-title":"BMJ Open"},{"key":"889_CR48","unstructured":"About amitriptyline for pain and migraine. NhsUk 2023. https:\/\/www.nhs.uk\/medicines\/amitriptyline-for-pain\/about-amitriptyline-for-pain-and-migraine\/ (accessed April 15, 2026)."},{"key":"889_CR49","unstructured":"How and when to take amlodipine. NhsUk 2022. https:\/\/www.nhs.uk\/medicines\/amlodipine\/how-and-when-to-take-amlodipine\/ (accessed April 15, 2026)."},{"key":"889_CR50","doi-asserted-by":"publisher","first-page":"e1000433","DOI":"10.1371\/journal.pgen.1000433","volume":"5","author":"F Takeuchi","year":"2009","unstructured":"Takeuchi F, McGinnis R, Bourgeois S, Barnes C, Eriksson N, Soranzo N, et al. A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose. PLOS Genet. 2009;5:e1000433. https:\/\/doi.org\/10.1371\/journal.pgen.1000433.","journal-title":"PLOS Genet"},{"key":"889_CR51","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1182\/blood-2003-09-3043","volume":"103","author":"E Shikata","year":"2004","unstructured":"Shikata E, Ieiri I, Ishiguro S, Aono H, Inoue K, Koide T, et al. Association of pharmacokinetic (CYP2C9) and pharmacodynamic (factors II, VII, IX, and X; proteins S and C; and \u03b3-glutamyl carboxylase) gene variants with warfarin sensitivity. Blood. 2004;103:2630\u20135. https:\/\/doi.org\/10.1182\/blood-2003-09-3043.","journal-title":"Blood"},{"key":"889_CR52","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/cpt.2149","volume":"110","author":"KR Crews","year":"2021","unstructured":"Crews KR, Monte AA, Huddart R, Caudle KE, Kharasch ED, Gaedigk A, et al. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy. Clin Pharmacol Ther. 2021;110:888\u201396. https:\/\/doi.org\/10.1002\/cpt.2149.","journal-title":"Clin Pharmacol Ther"},{"key":"889_CR53","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/cpt.597","volume":"102","author":"JK Hicks","year":"2017","unstructured":"Hicks JK, Sangkuhl K, Swen JJ, Ellingrod VL, M\u00fcller DJ, Shimoda K, et al. Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Clin Pharmacol Ther. 2017;102:37\u201344. https:\/\/doi.org\/10.1002\/cpt.597.","journal-title":"Clin Pharmacol Ther"},{"key":"889_CR54","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/sj.clpt.6100291","volume":"83","author":"I Rudberg","year":"2008","unstructured":"Rudberg I, Mohebi B, Hermann M, Refsum H, Molden E. Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients. Clin Pharmacol Ther. 2008;83:322\u20137. https:\/\/doi.org\/10.1038\/sj.clpt.6100291.","journal-title":"Clin Pharmacol Ther"},{"key":"889_CR55","doi-asserted-by":"publisher","first-page":"e84244","DOI":"10.1371\/journal.pone.0084244","volume":"8","author":"A Shiotani","year":"2013","unstructured":"Shiotani A, Murao T, Fujita Y, Fujimura Y, Sakakibara T, Nishio K, et al. Novel single nucleotide polymorphism markers for low dose aspirin-associated small bowel bleeding. PLoS ONE. 2013;8:e84244. https:\/\/doi.org\/10.1371\/journal.pone.0084244.","journal-title":"PLoS ONE"},{"key":"889_CR56","doi-asserted-by":"publisher","first-page":"e111887","DOI":"10.1371\/journal.pone.0111887","volume":"9","author":"S-W Shin","year":"2014","unstructured":"Shin S-W, Park BL, Chang H, Park JS, Bae D-J, Song H-J, et al. Exonic variants associated with development of aspirin exacerbated respiratory diseases. PLoS ONE. 2014;9:e111887. https:\/\/doi.org\/10.1371\/journal.pone.0111887.","journal-title":"PLoS ONE"},{"key":"889_CR57","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jaci.2003.12.012","volume":"113","author":"JH Choi","year":"2004","unstructured":"Choi JH, Lee KW, Oh HB, Lee KJ, Suh YJ, Park CS, et al. HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population. J Allergy Clin Immunol. 2004;113:562\u20134. https:\/\/doi.org\/10.1016\/j.jaci.2003.12.012.","journal-title":"J Allergy Clin Immunol"},{"key":"889_CR58","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.clpt.2006.09.009","volume":"80","author":"K-A Kim","year":"2006","unstructured":"Kim K-A, Park P-W, Lee O-J, Choi S-H, Min BH, Shin K-H, et al. Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects. Clin Pharmacol Ther. 2006;80:646\u201356. https:\/\/doi.org\/10.1016\/j.clpt.2006.09.009.","journal-title":"Clin Pharmacol Ther"},{"key":"889_CR59","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/biomedicines8040094","volume":"8","author":"M Saiz-Rodr\u00edguez","year":"2020","unstructured":"Saiz-Rodr\u00edguez M, Almenara S, Navares-G\u00f3mez M, Ochoa D, Rom\u00e1n M, Zubiaur P, et al. Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates. Biomedicines. 2020;8:94. https:\/\/doi.org\/10.3390\/biomedicines8040094.","journal-title":"Biomedicines"},{"key":"889_CR60","doi-asserted-by":"publisher","first-page":"e70140","DOI":"10.1002\/prp2.70140","volume":"13","author":"S Rognstad","year":"2025","unstructured":"Rognstad S, S\u00f8raas CL, Brunborg C, Halvorsen LV, Brobak KM, Olsen E, et al. Pharmacokinetic Variability of Amlodipine Serum Concentration and Effect on Blood Pressure in Patients Treated for Hypertension. Pharmacol Res Perspect. 2025;13:e70140. https:\/\/doi.org\/10.1002\/prp2.70140.","journal-title":"Pharmacol Res Perspect"},{"key":"889_CR61","doi-asserted-by":"publisher","first-page":"CD001547","DOI":"10.1002\/14651858.CD001547.pub2","volume":"2009","author":"L Toms","year":"2009","unstructured":"Toms L, Derry S, Moore RA, McQuay HJ. Single dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults. Cochrane Database Syst Rev. 2009;2009:CD001547. https:\/\/doi.org\/10.1002\/14651858.CD001547.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"889_CR62","doi-asserted-by":"publisher","first-page":"s13742","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience. 2015;4:s13742\u2013015. https:\/\/doi.org\/10.1186\/s13742-015-0047-8.","journal-title":"GigaScience"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00889-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-026-00889-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00889-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:02:32Z","timestamp":1787598152000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-026-00889-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":62,"alternative-id":["889"],"URL":"https:\/\/doi.org\/10.1007\/s43440-026-00889-9","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The UKB has obtained approval from the North West Multi-center Research Ethics Committee as a Research Tissue Bank approval (references: 11\/NW\/0382, 16\/NW\/0274, and 21\/NW\/0157). This approval covers all researchers using the UKB resource under an approved application; therefore, separate ethical approval was not required for this study. All participants provided written informed consent to participate in the study.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.Piech. and MK are founders of the bioinformatics company Intelliseq SA. The remaining authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}